This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

BiOasis Poster Being Presented At 17th Annual Blood-Brain Barrier Consortium Meeting

VANCOUVER, British Columbia, March 24, 2011 (GLOBE NEWSWIRE) -- biOasis Technologies Inc. (TSX-V:BTI) announces it is presenting Friday, March 25, 2011 a poster titled "A new Carrier for Delivery of Therapeutic Compounds Across the BBB for the Treatment of Brain Diseases" at the 17 th annual Blood-Brain Barrier Consortium meeting held in collaboration with the International Brain Barriers Society (IBBS) being held in Stevenson, Washington.

The poster provides a summary of key scientific accomplishments achieved by the Company, including results from its recent collaborations with the University of British Columbia and the National Research Council of Canada. The data from these collaborations further demonstrated that conjugations developed under the biOasis Transcend program cross the blood-brain barrier more efficiently than is possible with other approaches, that the conjugates enter the brain tissue, and that a conjugate incorporating doxorubicin increased survival time in animal models of glioblastoma, the most common and most aggressive type of primary brain tumor in humans. A copy of the poster can be downloaded from our web site at

"We are pleased to participate in this meeting, both as a corporate sponsor and by presenting a poster," stated Dr. Reinhard Gabathuler. "The IBBS meeting provides the opportunity to share and discuss our findings with thought leaders in the blood-brain barrier research community."

The IBBS is an international scientific and educational nonprofit organization that: encourages, promotes and advocates scientific and clinical research on the biological barriers in the central nervous system (CNS); accumulates information about barriers in the CNS and promotes its dissemination to scientists, physicians, patients, policy makers, public and private funding agencies and other concerned parties, and; educates the general public and medical profession about the existence, diagnosis and treatment of disorders involving the barriers of the CNS.

1 of 3

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free
AAPL $93.10 -1.20%
FB $117.53 -0.45%
GOOG $704.87 1.30%
TSLA $210.31 -5.50%
YHOO $37.13 3.10%


Chart of I:DJI
DOW 17,641.02 -19.69 -0.11%
S&P 500 2,050.63 -0.49 -0.02%
NASDAQ 4,717.0940 -8.5450 -0.18%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs